| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ankyrin 3 | 0.578 | 0.654 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 3 | 2017 | 2017 | ||||||||
|
ankyrin repeat domain 16 | 0.890 | 0.192 | 7.4E-10 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2017 | 2017 | ||||||||
|
ankyrin repeat domain 55 | 0.650 | 0.462 | 6.8E-08 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2017 | 2017 | ||||||||
|
adaptor related protein complex 3 subunit beta 1 | 0.619 | 0.808 | 0.62 |
|
disease | 0.100 | None | 1.000 | 1 | 16 | 2017 | 2017 | ||||||||
|
aprataxin and PNKP like factor | 0.780 | 0.269 | 1.3E-18 |
|
disease | 0.100 | None | 1.000 | 1 | 3 | 2017 | 2017 | ||||||||
|
Rho GTPase activating protein 28 | 0.890 | 0.077 | 2.6E-09 |
|
disease | 0.100 | None | 1.000 | 1 | 11 | 2017 | 2017 | ||||||||
|
Rho GTPase activating protein 31 | 0.581 | 0.615 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 5 | 2017 | 2017 | ||||||||
|
Rho guanine nucleotide exchange factor 10 like | 0.792 | 0.192 | 4.7E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 15 | 2017 | 2017 | ||||||||
|
Rho/Rac guanine nucleotide exchange factor 18 | 0.700 | 0.308 | 1.8E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 5 | 2017 | 2017 | ||||||||
|
Rho guanine nucleotide exchange factor 33 | 1.000 | 0.038 | 7.8E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 4 | 2017 | 2017 | ||||||||
|
AT-rich interaction domain 5A | 0.821 | 0.269 | 0.95 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2017 | 2017 | ||||||||
|
ADP ribosylation factor like GTPase 5C | 1.000 | 0.038 | 0.31 |
|
disease | 0.100 | None | 1.000 | 1 | 3 | 2017 | 2017 | ||||||||
|
ankyrin repeat and SOCS box containing 15 | 0.792 | 0.231 | 1.8E-15 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
ankyrin repeat and SOCS box containing 2 | 0.769 | 0.308 | 6.8E-15 |
|
disease | 0.110 | None | 1.000 | 1 | 2 | 2017 | 2017 | ||||||||
|
anti-silencing function 1B histone chaperone | 0.769 | 0.269 | 6.3E-05 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2017 | 2017 | ||||||||
|
acid sensing ion channel subunit 2 | 0.653 | 0.538 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 5 | 2017 | 2017 | ||||||||
|
asparaginase and isoaspartyl peptidase 1 | 0.494 | 0.808 | 2.8E-05 |
|
disease | 0.180 | None | 1.000 | 1 | 7 | 2010 | 2019 | ||||||||
|
activating transcription factor 2 | 0.551 | 0.808 | 0.99 |
|
disease | 0.110 | None | 1.000 | 1 | 14 | 2017 | 2018 | ||||||||
|
atlastin GTPase 2 | 0.861 | 0.231 | 1.2E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 4 | 2017 | 2017 | ||||||||
|
ATPase secretory pathway Ca2+ transporting 2 | 0.769 | 0.308 | 5.0E-60 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2017 | 2017 | ||||||||
|
ATPase H+ transporting V0 subunit e1 pseudogene 1 | 1.000 | 0.038 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||||||
|
ATPase phospholipid transporting 8A2 | 0.659 | 0.577 | 1.2E-12 |
|
disease | 0.100 | None | 1.000 | 1 | 4 | 2017 | 2017 | ||||||||
|
ATPase phospholipid transporting 8B1 | 0.610 | 0.500 | 2.8E-10 |
|
disease | 0.100 | None | 1.000 | 1 | 7 | 2017 | 2017 | ||||||||
|
activator of transcription and developmental regulator AUTS2 | 0.569 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 12 | 2017 | 2017 | ||||||||
|
B3GALT1 antisense RNA 1 | 1.000 | 0.038 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2017 | 2017 |